A single-cell rapid sequencing analysis method

By using microfluidic devices and magnetic stirring technology in single-cell high-throughput droplet sequencing technology, combining polyvinyl alcohol, polysorbate and polyvinylpyrrolidone, the problems of droplet stability and mRNA enrichment efficiency are solved, and the problems of droplet stability and mRNA enrichment efficiency are improved. Quality and efficiency of sequencing analysis.

CN117327774BActive Publication Date: 2024-11-26GUANGZHOU JUNRUIKANG MEDICAL LAB CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202311454242.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-11-03
Publication Date
2024-11-26
Estimated Expiration
2043-11-03

AI Technical Summary

Technical Problem

In single-cell high-throughput droplet sequencing technology, the oil phase cannot effectively wrap the aqueous phase, resulting in the damage of droplets before cell lysis, affecting the efficiency of Poly(dT) enrichment of mRNA, and thus affecting the sequencing results.

Method used

The cell suspension, microbead suspension with molecular barcode and cell lysate are pumped into the droplet generation oil by using a microfluidic device, and stable droplets are formed by magnetic stirring, and polyvinyl alcohol is used during the droplet generation. Polysorbate and polyvinylpyrrolidone are used to improve the stability of micro droplets and mRNA enrichment efficiency.

Benefits of technology

It significantly reduces the breakage rate of micro droplets, improves the efficiency of Poly(dT) enrichment mRNA, and enhances the effectiveness of sequencing analysis and sample utilization.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004529945620000111
    Figure BDA0004529945620000111
  • Figure BDA0004529945620000121
    Figure BDA0004529945620000121
Patent Text Reader

Abstract

The present invention relates to a single-cell rapid sequencing and analysis method, and belongs to the field of gene sequencing technology. The present invention first pumps a cell suspension, a microbead suspension with a molecular barcode, and a cell lysate to a microfluidic device, converges to form a laminar flow, and then converges with a droplet-generating oil to form monodispersed droplets, then lyses the droplets, and finally performs PCR amplification and sequencing analysis. The present invention adds polyvinyl alcohol to the cell suspension, and adds polysorbate and polyvinyl pyrrolidone to the microbead suspension with a molecular barcode. When the two are pumped into the same droplet-generating oil, polyvinyl alcohol, polysorbate, and polyvinyl pyrrolidone synergistically increase the stability of the generated droplets, effectively reducing the breakage rate of the droplets, and polysorbate and polyvinyl pyrrolidone can also improve the efficiency of mRNA enrichment in Poly (dT), thereby improving the sample efficiency and avoiding waste.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of gene sequencing and relates to a single-cell rapid sequencing analysis method. Background Art

[0002] Cells are the basic units of biological structure and function, and their morphological types vary greatly. Cell genomics can be used to describe cell characteristics and functions, but its ease of use and scale limitations have hindered its widespread application.

[0003] Single-cell high-throughput droplet sequencing (Drop-seq) technology isolates cells in tiny droplets and installs barcode primers for amplification, thereby detecting thousands of cells. Drop-seq can help biologists further discover and classify human cells, map the cell diversity of complex tissues such as the brain, better understand stem cell differentiation, and obtain more genetic information on diseases. However, the oil phase in this technology cannot wrap the water phase well, resulting in the droplets being damaged before the cells are lysed, which makes Poly(dT) unable to efficiently enrich mRNA, affecting subsequent sequencing results. Summary of the invention

[0004] The object of the present invention is to provide a single-cell rapid sequencing analysis method, which has the characteristics of good droplet stability and high efficiency of Poly (dT) enrichment of mRNA.

[0005] The purpose of the present invention can be achieved through the following technical solutions:

[0006] A single-cell rapid sequencing and analysis method comprises the following steps: firstly, a cell suspension, a microbead suspension with a molecular barcode and a cell lysate are pumped into a microfluidic device, converged to form a laminar flow, then converged with droplet generation oil to form monodisperse droplets, then the droplets are lysed, and finally PCR amplification is performed, and sequencing analysis is performed.

[0007] As a preferred technical solution of the present invention, the microfluidic device comprises: a core is a glass microfluidic chip, which is connected to four input pipes and one output pipe.

[0008] As a preferred technical solution of the present invention, the microbeads with molecular barcodes are composed of primers and magnetic beads, and the sequence of the primers includes four parts: PCR primer, 12bp Cell Barcode, 8bp UMI and 30bp Poly (dT) sequence.

[0009] As a preferred technical solution of the present invention, the droplets are obtained by the following steps:

[0010] W1. The cell suspension was loaded into a 3 mL plastic syringe A, and equal volumes of cell lysate and microbead suspension with molecular barcodes were loaded into a 3 mL plastic syringe B; a 6.4 mm magnetic rotor was added to the plastic syringe B and controlled by a magnetic stirrer;

[0011] W2. The droplet generation oil was loaded into 10 mL plastic syringes C and D. The four syringes were connected to the four input pipes of the microfluidic device through 0.38 mm inner diameter PEEK tubes, and the flow rate in the plastic syringes A and B was 4.1 mL / h and the flow rate of the droplet generation oil was 14 mL / h using a syringe pump;

[0012] W3. Observe the generation and flow of droplets under an optical microscope at a magnification of 10 times; collect the droplets in a centrifuge tube;

[0013] W4. During droplet generation, the molecularly barcoded microbeads are kept in suspension by continuous, gentle magnetic stirring.

[0014] As a preferred technical solution of the present invention, the cell suspension is obtained through a peripheral blood PBMC separation step or a bone marrow blood PBMC separation step;

[0015] The peripheral blood PBMC separation step comprises the following operations:

[0016] X1. Take human peripheral blood and add PBS buffer at a volume ratio of 1:1 to obtain diluted blood;

[0017] X2. Take the lymphocyte separation fluid and place it in a sterile centrifuge tube for later use;

[0018] X3. Take the diluted blood and slowly add it along the wall of the test tube 1 cm above the lymphocyte separation solution, so that the diluted blood overlaps with the lymphocyte separation solution and forms a clear interface with the lymphocyte separation solution;

[0019] X4. Centrifuge. Four layers are formed in the centrifuge tube: the first layer is the diluent layer, the second layer is the mononuclear cell layer in the form of a white film, the third layer is the transparent separation liquid layer, and the fourth layer is the red blood cell layer;

[0020] X5. Aspirate the mononuclear cell layer in the middle that is like a white film, add 5 volumes of PBS buffer and wash 1 to 2 times, centrifuging at 300 xg for 10 minutes each time;

[0021] X6. After centrifugation, discard the supernatant, add PBS buffer and polyvinyl alcohol to resuspend, and control the concentration of mononuclear cells to 60 cells / μL;

[0022] The bone marrow blood PBMC separation step comprises the following operations:

[0023] Y1. Take the lymphocyte separation fluid and place it in a sterile centrifuge tube for later use;

[0024] Y2. Take bone marrow blood at a volume ratio of 5:1, add PBS buffer to dilute the blood, and centrifuge at 300ⅹg for 5 minutes; then discard the supernatant, add 3 times the volume of PBS buffer to dilute the blood, and centrifuge at 300ⅹg for 10 minutes;

[0025] Y3. After centrifugation, discard the supernatant, add 2 times the volume of bone marrow blood in PBS buffer, resuspend, and filter to obtain pretreated bone marrow blood;

[0026] Y4. Take the pretreated bone marrow blood and slowly add it along the wall of the test tube 1 cm above the lymphocyte separation solution so that the pretreated bone marrow blood overlaps the lymphocyte separation solution and forms a clear interface with the lymphocyte separation solution;

[0027] Y5. Centrifuge. Five layers are formed in the centrifuge tube: the top layer is plasma, and between the plasma and lymphocyte separation fluid is a mononuclear cell layer in the form of a white film;

[0028] Y6. Aspirate the mononuclear cell layer in the middle that is like a white film, add 5 volumes of PBS buffer and wash 1 to 2 times, centrifuging at 300 xg for 10 min each time;

[0029] Y7. After centrifugation, discard the supernatant, add PBS buffer and polyvinyl alcohol to resuspend, and control the concentration of mononuclear cells to 60 cells / μL.

[0030] As a preferred technical solution of the present invention, the microbead suspension with molecular barcodes is prepared by the following steps:

[0031] The microbeads with molecular barcodes were washed twice with 100% ethanol and twice with TE / TW, centrifuged at 1000ⅹg for 1 min, and then the supernatant was discarded. The microbeads were resuspended with TE / TW, filtered with a 100 μm filter, placed in a centrifuge tube, washed with the added DropSeqlysis buffer, centrifuged at 1000ⅹg for 1 min, and the supernatant was discarded. The microbeads were then resuspended in a mixture containing 1 mM DLB buffer and 50 mM DTT, and polysorbate and polyvinyl pyrrolidone were added to control the concentration of microbeads with molecular barcodes to be approximately 120 beads / μL.

[0032] The TE / TW contains 10 mM Tris pH 8.0, 1 mM EDTA and 0.01% Tween;

[0033] The DropSeq lysis buffer contains 1 mM DLB buffer, 200 mM Tris pH 7.5, 6% Ficoll PM-400, 0.2% Sarkosyl and 20 mM EDTA.

[0034] As a preferred technical solution of the present invention, the volume ratio of the PBS buffer and polyvinyl alcohol described in steps X6 and Y7 is 3-5:2-4.

[0035] As a preferred technical solution of the present invention, the volume ratio of the mixed solution, polysorbate and polyvinyl pyrrolidone is 35-40:7-9:1-3.

[0036] As a preferred technical solution of the present invention, the lysis droplet comprises the following operations:

[0037] Z1. Add 6×SSC buffer to the centrifuge tube collecting the microdroplets at room temperature, and then use a pipette to remove the oil at the bottom of the microdroplets;

[0038] Z2. Add perfluoro-1-octanol, shake the test tube for 20 seconds to break the droplets, and then centrifuge at 1000ⅹg for 1 minute.

[0039] Beneficial effects of the present invention:

[0040] The present invention adds polyvinyl alcohol to a cell suspension, and adds polysorbate and polyvinyl pyrrolidone to a microbead suspension with a molecular barcode. When the two are pumped into the same droplet generation oil, polyvinyl alcohol, polysorbate and polyvinyl pyrrolidone synergistically increase the stability of the generated microdroplets, effectively reducing the breakage rate of the microdroplets. At the same time, polysorbate and polyvinyl pyrrolidone can also increase the efficiency of mRNA enrichment in Poly (dT), thereby improving the sample efficiency and avoiding waste. DETAILED DESCRIPTION

[0041] In order to further illustrate the technical means and effects adopted by the present invention to achieve the predetermined invention purpose, the specific implementation methods, structures, features and effects of the present invention are described in detail below in combination with the embodiments.

[0042] Example 1

[0043] A single-cell rapid sequencing and analysis method comprises the following steps: firstly, a cell suspension, a microbead suspension with a molecular barcode and a cell lysate are pumped into a microfluidic device, converged to form a laminar flow, then converged with droplet generation oil to form monodisperse droplets, then the droplets are lysed, and finally PCR amplification is performed, and sequencing analysis is performed.

[0044] The microfluidic device comprises: a core is a glass microfluidic chip, which is connected to four input pipes and one output pipe.

[0045] The microbeads with molecular barcodes are composed of primers and magnetic beads, and the primer sequence includes four parts: PCR primer, 12 bp Cell Barcode, 8 bp UMI and 30 bp Poly (dT) sequence.

[0046] The droplets are obtained specifically by the following steps:

[0047] W1. The cell suspension was loaded into a 3 mL plastic syringe A, and equal volumes of cell lysate and microbead suspension with molecular barcodes were loaded into a 3 mL plastic syringe B; a 6.4 mm magnetic rotor was added to the plastic syringe B and controlled by a magnetic stirrer;

[0048] W2. The droplet generation oil was loaded into 10 mL plastic syringes C and D. The four syringes were connected to the four input pipes of the microfluidic device through 0.38 mm inner diameter PEEK tubes, and the flow rate in the plastic syringes A and B was 4.1 mL / h and the flow rate of the droplet generation oil was 14 mL / h using a syringe pump;

[0049] W3. Observe the generation and flow of droplets under an optical microscope at a magnification of 10 times; collect the droplets in a 50 mL centrifuge tube;

[0050] W4. During droplet generation, the molecularly barcoded microbeads are kept in suspension by continuous, gentle magnetic stirring.

[0051] The cell suspension is obtained by separating peripheral blood PBMC;

[0052] The peripheral blood PBMC separation step comprises the following operations:

[0053] X1. Take human peripheral blood and add PBS buffer at a volume ratio of 1:1 to obtain diluted blood;

[0054] X2. Take 5 mL of lymphocyte separation solution and place it in a 15 mL sterile centrifuge tube for later use;

[0055] X3. Take the diluted blood and slowly add it along the wall of the test tube 1 cm above the lymphocyte separation solution, so that the diluted blood overlaps with the lymphocyte separation solution and forms a clear interface with the lymphocyte separation solution;

[0056] X4. Centrifuge at 2000rpm for 20min. At this time, 4 layers are formed in the centrifuge tube: the first layer is the diluent layer, the second layer is the mononuclear cell layer in the form of a white film, the third layer is the transparent separation liquid layer, and the fourth layer is the red blood cell layer;

[0057] X5. Carefully aspirate the mononuclear cell layer in the middle that is like a white film, and try to aspirate all the mononuclear cells. Wash once with 5 times the volume of PBS buffer, and centrifuge at 300×g for 10 minutes.

[0058] X6. After centrifugation, discard the supernatant and resuspend with PBS buffer and polyvinyl alcohol. The volume ratio of PBS buffer and polyvinyl alcohol is 3:2. The concentration of mononuclear cells is controlled to be 60 cells / μL.

[0059] The microbead suspension with molecular barcodes is prepared by the following steps:

[0060] The microbeads with molecular barcodes were washed twice with 30 ml 100% ethanol and twice with 30 mL TE / TW, centrifuged at 1000 xg for 1 min, and then the supernatant was discarded. The microbeads were resuspended with 10 mL TE / TW, filtered with a 100 μm filter, placed in a 50 mL centrifuge tube, washed with 500 μL DropSeq lysis buffer, centrifuged at 1000 xg for 1 min, and the supernatant was discarded; then the microbeads were resuspended in a mixture containing 1 mM DLB buffer and 50 mM DTT, and polysorbate and polyvinyl pyrrolidone were added to control the concentration of microbeads with molecular barcodes to be about 120 beads / μL, and the volume ratio of the mixture, polysorbate, and polyvinyl pyrrolidone was 35:7:1;

[0061] The TE / TW contains 10 mM Tris pH 8.0, 1 mM EDTA and 0.01% Tween;

[0062] The DropSeq lysis buffer contains 1 mM DLB buffer, 200 mM Tris pH 7.5, 6% Ficoll PM-400, 0.2% Sarkosyl and 20 mM EDTA.

[0063] The lysis droplet comprises the following operations:

[0064] Z1. Add 30 mL of 6×SSC buffer to the centrifuge tube collecting the microdroplets at room temperature, and then use a pipette to remove the oil at the bottom of the microdroplets;

[0065] Z2. Add 600 μL of perfluoro-1-octanol, shake the test tube for 20 seconds to break the droplets, and then centrifuge at 1000ⅹg for 1 minute.

[0066] Example 2

[0067] A single-cell rapid sequencing and analysis method comprises the following steps: firstly, a cell suspension, a microbead suspension with a molecular barcode and a cell lysate are pumped into a microfluidic device, converged to form a laminar flow, then converged with droplet generation oil to form monodisperse droplets, then the droplets are lysed, and finally PCR amplification is performed, and sequencing analysis is performed.

[0068] The microfluidic device comprises: a core is a glass microfluidic chip, which is connected to four input pipes and one output pipe.

[0069] The microbeads with molecular barcodes are composed of primers and magnetic beads, and the primer sequence includes four parts: PCR primer, 12 bp Cell Barcode, 8 bp UMI and 30 bp Poly (dT) sequence.

[0070] The droplets are obtained specifically by the following steps:

[0071] W1. The cell suspension was loaded into a 3 mL plastic syringe A, and equal volumes of cell lysate and microbead suspension with molecular barcodes were loaded into a 3 mL plastic syringe B; a 6.4 mm magnetic rotor was added to the plastic syringe B and controlled by a magnetic stirrer;

[0072] W2. The droplet generation oil was loaded into 10 mL plastic syringes C and D. The four syringes were connected to the four input pipes of the microfluidic device through 0.38 mm inner diameter PEEK tubes, and the flow rate in the plastic syringes A and B was 4.1 mL / h and the flow rate of the droplet generation oil was 14 mL / h using a syringe pump;

[0073] W3. Observe the generation and flow of droplets under an optical microscope at a magnification of 10 times; collect the droplets in a 50 mL centrifuge tube;

[0074] W4. During droplet generation, the molecularly barcoded microbeads are kept in suspension by continuous, gentle magnetic stirring.

[0075] The cell suspension is obtained by separating PBMC from bone marrow blood;

[0076] The bone marrow blood PBMC separation step comprises the following operations:

[0077] Y1. Take 5 mL of lymphocyte separation solution and place it in a 15 mL sterile centrifuge tube for later use;

[0078] Y2. Take bone marrow blood at a volume ratio of 5:1, add PBS buffer to dilute the blood, and centrifuge at 300ⅹg for 5 minutes; then discard the supernatant, add PBS buffer to dilute the blood at a volume ratio of 3:1, and centrifuge at 300ⅹg for 10 minutes;

[0079] Y3. After centrifugation, discard the supernatant, add 2 times the volume of bone marrow blood in PBS buffer, resuspend, and filter to obtain pretreated bone marrow blood;

[0080] Y4. Take the pretreated bone marrow blood and slowly add it along the wall of the test tube 1 cm above the lymphocyte separation solution so that the pretreated bone marrow blood overlaps the lymphocyte separation solution and forms a clear interface with the lymphocyte separation solution;

[0081] Y5. Centrifuge at 2000 rpm for 20 min. Five layers are formed in the centrifuge tube: the top layer is plasma, and between the plasma and lymphocyte separation fluid is a mononuclear cell layer in the form of a white film;

[0082] Y6. Carefully aspirate the mononuclear cell layer in the middle that is like a white film, and try to aspirate all the mononuclear cells. Wash twice with 5 times the volume of PBS buffer, and centrifuge at 300g for 10 minutes each time.

[0083] Y7. After centrifugation, discard the supernatant and resuspend with PBS buffer and polyvinyl alcohol. The volume ratio of PBS buffer and polyvinyl alcohol is 4:3. The concentration of mononuclear cells is controlled to be 60 cells / μL.

[0084] The microbead suspension with molecular barcodes is prepared by the following steps:

[0085] The microbeads with molecular barcodes were washed twice with 30 ml 100% ethanol and twice with 30 mL TE / TW, centrifuged at 1000 xg for 1 min, and then the supernatant was discarded. The microbeads were resuspended with 10 mL TE / TW, filtered with a 100 μm filter, placed in a 50 mL centrifuge tube, washed with 500 μL DropSeq lysis buffer, centrifuged at 1000 xg for 1 min, and the supernatant was discarded; the microbeads were then resuspended in a mixture containing 1 mM DLB buffer and 50 mM DTT, and polysorbate and polyvinyl pyrrolidone were added to control the concentration of microbeads with molecular barcodes to be approximately 120 beads / μL, and the volume ratio of the mixture, polysorbate, and polyvinyl pyrrolidone was 37:8:2;

[0086] The TE / TW contains 10 mM Tris pH 8.0, 1 mM EDTA and 0.01% Tween;

[0087] The DropSeq lysis buffer contains 1 mM DLB buffer, 200 mM Tris pH 7.5, 6% Ficoll PM-400, 0.2% Sarkosyl and 20 mM EDTA.

[0088] The lysis droplet comprises the following operations:

[0089] Z1. Add 30 mL of 6×SSC buffer to the centrifuge tube collecting the microdroplets at room temperature, and then use a pipette to remove the oil at the bottom of the microdroplets;

[0090] Z2. Add 600 μL of perfluoro-1-octanol, shake the test tube for 20 seconds to break the droplets, and then centrifuge at 1000ⅹg for 1 minute.

[0091] Example 3

[0092] A single-cell rapid sequencing and analysis method comprises the following steps: firstly, a cell suspension, a microbead suspension with a molecular barcode and a cell lysate are pumped into a microfluidic device, converged to form a laminar flow, then converged with droplet generation oil to form monodisperse droplets, then the droplets are lysed, and finally PCR amplification is performed, and sequencing analysis is performed.

[0093] The microfluidic device comprises: a core is a glass microfluidic chip, which is connected to four input pipes and one output pipe.

[0094] The microbeads with molecular barcodes are composed of primers and magnetic beads, and the primer sequence includes four parts: PCR primer, 12 bp Cell Barcode, 8 bp UMI and 30 bp Poly (dT) sequence.

[0095] The droplets are obtained specifically by the following steps:

[0096] W1. The cell suspension was loaded into a 3 mL plastic syringe A, and equal volumes of cell lysate and microbead suspension with molecular barcodes were loaded into a 3 mL plastic syringe B; a 6.4 mm magnetic rotor was added to the plastic syringe B and controlled by a magnetic stirrer;

[0097] W2. The droplet generation oil was loaded into 10 mL plastic syringes C and D. The four syringes were connected to the four input pipes of the microfluidic device through 0.38 mm inner diameter PEEK tubes, and the flow rate in the plastic syringes A and B was 4.1 mL / h and the flow rate of the droplet generation oil was 14 mL / h using a syringe pump;

[0098] W3. Observe the generation and flow of droplets under an optical microscope at a magnification of 10 times; collect the droplets in a 50 mL centrifuge tube;

[0099] W4. During droplet generation, the molecularly barcoded microbeads are kept in suspension by continuous, gentle magnetic stirring.

[0100] The cell suspension is obtained by separating peripheral blood PBMC;

[0101] The peripheral blood PBMC separation step comprises the following operations:

[0102] X1. Take human peripheral blood and add PBS buffer at a volume ratio of 1:1 to obtain diluted blood;

[0103] X2. Take 5 mL of lymphocyte separation solution and place it in a 15 mL sterile centrifuge tube for later use;

[0104] X3. Take the diluted blood and slowly add it along the wall of the test tube 1 cm above the lymphocyte separation solution, so that the diluted blood overlaps with the lymphocyte separation solution and forms a clear interface with the lymphocyte separation solution;

[0105] X4. Centrifuge at 2000rpm for 20min. At this time, 4 layers are formed in the centrifuge tube: the first layer is the diluent layer, the second layer is the mononuclear cell layer in the form of a white film, the third layer is the transparent separation liquid layer, and the fourth layer is the red blood cell layer;

[0106] X5. Carefully aspirate the mononuclear cell layer in the middle that is like a white film, and try to aspirate all the mononuclear cells. Wash twice with 5 times the volume of PBS buffer, and centrifuge at 300×g for 10 minutes each time.

[0107] X6. After centrifugation, discard the supernatant and resuspend with PBS buffer and polyvinyl alcohol. The volume ratio of PBS buffer and polyvinyl alcohol is 5:4. The concentration of mononuclear cells is controlled to be 60 cells / μL.

[0108] The microbead suspension with molecular barcodes is prepared by the following steps:

[0109] The microbeads with molecular barcodes were washed twice with 30 ml 100% ethanol and twice with 30 mL TE / TW, centrifuged at 1000 xg for 1 min, and then the supernatant was discarded. The microbeads were resuspended with 10 mL TE / TW, filtered with a 100 μm filter, placed in a 50 mL centrifuge tube, washed with 500 μL DropSeq lysis buffer, centrifuged at 1000 xg for 1 min, and the supernatant was discarded; the microbeads were then resuspended in a mixture containing 1 mM DLB buffer and 50 mM DTT, and polysorbate and polyvinyl pyrrolidone were added to control the concentration of microbeads with molecular barcodes to be approximately 120 beads / μL, and the volume ratio of the mixture, polysorbate, and polyvinyl pyrrolidone was 40:9:3;

[0110] The TE / TW contains 10 mM Tris pH 8.0, 1 mM EDTA and 0.01% Tween;

[0111] The DropSeq lysis buffer contains 1 mM DLB buffer, 200 mM Tris pH 7.5, 6% Ficoll PM-400, 0.2% Sarkosyl and 20 mM EDTA.

[0112] The lysis droplet comprises the following operations:

[0113] Z1. Add 30 mL of 6×SSC buffer to the centrifuge tube collecting the microdroplets at room temperature, and then use a pipette to remove the oil at the bottom of the microdroplets;

[0114] Z2. Add 600 μL of perfluoro-1-octanol, shake the test tube for about 20 seconds to break the droplets, and then centrifuge at 1000ⅹg for 1 minute.

[0115] Comparative Example 1

[0116] In step X6, no polyvinyl alcohol is added, and the remaining operations are the same as those in Example 3.

[0117] Comparative Example 2

[0118] Without adding polysorbate, the remaining operations were carried out in accordance with Example 3.

[0119] Comparative Example 3

[0120] No polyvinyl pyrrolidone was added, and the remaining operations were the same as in Example 3.

[0121] Performance Testing

[0122] The morphology of the droplets generated in step W3 of Examples 1 to 3 and Comparative Examples 1 to 3 was observed and the number of droplet breakages ( / 100 drops) was recorded. The results are shown in Table 1 below.

[0123] Table 1 Observation results of droplet morphology

[0124]

[0125]

[0126] The above description is only a preferred embodiment of the present invention and does not limit the present invention in any form. Although the present invention has been disclosed as a preferred embodiment as above, it is not used to limit the present invention. Any technical personnel in this field can make some changes or modify the technical contents disclosed above into equivalent embodiments without departing from the scope of the technical solution of the present invention. However, any brief modifications, equivalent changes and modifications made to the above embodiments based on the technical essence of the present invention without departing from the content of the technical solution of the present invention are still within the scope of the technical solution of the present invention.

Claims

1. A single-cell rapid sequencing analysis method, characterized in that: The method comprises the following steps: firstly, pumping a cell suspension, a microbead suspension with a molecular barcode, and a cell lysate to a microfluidic device, converging them to form a laminar flow, then converging them with droplet generation oil to form monodisperse droplets, then lysing the droplets, and finally performing PCR amplification and sequencing analysis; The microfluidic device comprises: a core is a glass microfluidic chip, which is connected to four input pipes and one output pipe; The microbeads with molecular barcodes are composed of primers and magnetic beads, and the primer sequence includes four parts: PCR primer, 12 bp CellBarcode, 8 bp UMI and 30 bp Poly(dT) sequence; The droplets are obtained specifically by the following steps: W1. The cell suspension was loaded into a 3 mL plastic syringe A, and equal volumes of cell lysate and microbead suspension with molecular barcodes were loaded into a 3 mL plastic syringe B; a 6.4 mm magnetic rotor was added to the plastic syringe B and controlled by a magnetic stirrer; W2. The droplet generation oil was loaded into 10 mL plastic syringes C and D. The four syringes were connected to the four input pipes of the microfluidic device through 0.38 mm inner diameter PEEK tubes, and the flow rate in the plastic syringes A and B was 4.1 mL / h and the flow rate of the droplet generation oil was 14 mL / h using a syringe pump; W3. Observe the generation and flow of droplets under an optical microscope at a magnification of 10 times; collect the droplets in a centrifuge tube; W4. During droplet generation, the molecular barcoded microbeads are kept in suspension by continuous, gentle magnetic stirring; The cell suspension is obtained through a peripheral blood PBMC separation step or a bone marrow blood PBMC separation step; The peripheral blood PBMC separation step comprises the following operations: X1. Take human peripheral blood and add PBS buffer at a volume ratio of 1:1 to obtain diluted blood; X2. Take the lymphocyte separation fluid and place it in a sterile centrifuge tube for later use; X3. Take the diluted blood and slowly add it along the wall of the test tube 1 cm above the lymphocyte separation solution, so that the diluted blood overlaps with the lymphocyte separation solution and forms a clear interface with the lymphocyte separation solution; X4. Centrifuge. Four layers are formed in the centrifuge tube: the first layer is the diluent layer, the second layer is the mononuclear cell layer in the form of a white film, the third layer is the transparent separation liquid layer, and the fourth layer is the red blood cell layer; X5. Aspirate the mononuclear cell layer in the middle that is like a white film, add 5 volumes of PBS buffer and wash 1 to 2 times, centrifuging at 300 xg for 10 minutes each time; X6. After centrifugation, discard the supernatant, add PBS buffer and polyvinyl alcohol to resuspend, and control the concentration of mononuclear cells to 60 cells / μL; The bone marrow blood PBMC separation step comprises the following operations: Y1. Take the lymphocyte separation fluid and place it in a sterile centrifuge tube for later use; Y2. Take bone marrow blood at a volume ratio of 5:1, add PBS buffer to dilute the blood, and centrifuge at 300ⅹg for 5 minutes; then discard the supernatant, add 3 times the volume of PBS buffer to dilute the blood, and centrifuge at 300ⅹg for 10 minutes; Y3. After centrifugation, discard the supernatant, add 2 times the volume of bone marrow blood in PBS buffer, resuspend, and filter to obtain pretreated bone marrow blood; Y4. Take the pretreated bone marrow blood and slowly add it along the wall of the test tube 1 cm above the lymphocyte separation solution so that the pretreated bone marrow blood overlaps the lymphocyte separation solution and forms a clear interface with the lymphocyte separation solution; Y5. Centrifuge. Five layers are formed in the centrifuge tube: the top layer is plasma, and between the plasma and lymphocyte separation fluid is a mononuclear cell layer in the form of a white film; Y6. Aspirate the mononuclear cell layer in the middle that is like a white film, add 5 times the volume of PBS buffer and wash 1 to 2 times, centrifuging at 300g for 10 minutes each time; Y7. After centrifugation, discard the supernatant, add PBS buffer and polyvinyl alcohol to resuspend, and control the concentration of mononuclear cells to 60 cells / μL; The microbead suspension with molecular barcodes is prepared by the following steps: The microbeads with molecular barcodes were washed twice with 100% ethanol and twice with TE / TW, centrifuged at 1000ⅹg for 1 min, and then the supernatant was discarded. The microbeads were resuspended with TE / TW, filtered with a 100 μm filter, placed in a centrifuge tube, washed with DropSeq lysis buffer, centrifuged at 1000ⅹg for 1 min, and the supernatant was discarded. The microbeads were then resuspended in a mixture containing 1 mM DLB buffer and 50 mM DTT, and polysorbate and polyvinyl pyrrolidone were added to control the concentration of microbeads with molecular barcodes to be approximately 120 beads / μL. The TE / TW contains 10 mM Tris pH 8.0, 1 mM EDTA and 0.01% Tween; The DropSeq lysis buffer contains 1 mM DLB buffer, 200 mM Tris pH 7.5, 6% Ficoll PM-400, 0.2% Sarkosyl and 20 mM EDTA.

2. A single-cell rapid sequencing analysis method according to claim 1, characterized in that: The volume ratio of PBS buffer and polyvinyl alcohol in steps X6 and Y7 is 3-5:2-4.

3. A single-cell rapid sequencing analysis method according to claim 1, characterized in that: The volume ratio of the mixed solution, polysorbate and polyvinyl pyrrolidone is 35-40:7-9:1-3.

4. A single-cell rapid sequencing analysis method according to claim 1, characterized in that: The lysis droplet comprises the following operations: Z1. Add 6×SSC buffer to the centrifuge tube collecting the microdroplets at room temperature, and then use a pipette to remove the oil at the bottom of the microdroplets; Z2. Add perfluoro-1-octanol, shake the test tube for 20 seconds to break the droplets, and then centrifuge at 1000ⅹg for 1 minute.